drugset / Trial / NCT00002986

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

NCT00002986

Phase 1 Completed 36 enrolled Duke University
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of topotecan plus carmustine in patients with recurrent primary malignant glioma.

Timeline

Start
1997-02
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Topotecan Small molecule
Subject carmustine Small molecule